Moderna starts testing COVID-19 vaccine on young children, infants
Mar 17, 2021
New York [US], March 17 : Moderna has begun testing its COVID-19 vaccine on children and infants between the ages of six months and 12 years old in a study, as the pharmaceutical company seeks to expand approval for its vaccine to children, the company said on Tuesday.